Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid
Abstract Background Mesenchymal stem cells (MSCs) have entered the clinic as an Advanced Therapy Medicinal Product and are currently evaluated in a wide range of studies for tissue regeneration or in autoimmune disorders. Various efforts have been made to standardize and optimize expansion and manuf...
Main Authors: | Madeleine C. Killer, Philipp Nold, Katharina Henkenius, Lea Fritz, Tabea Riedlinger, Christina Barckhausen, Miriam Frech, Holger Hackstein, Andreas Neubauer, Cornelia Brendel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-017-0553-y |
Similar Items
-
Effect of valproic acid on stem cell development and functional recovery of ischemic mice.
Published: (2012) -
The effect of carbamazepine on valproic acid metabolism
by: Panesar, Sukhbinder Kaur
Published: (2010) -
Pharmacokinetics of two monounsaturated metabolites of valproic acid in the rat
by: Singh, Kuldeep
Published: (2010) -
GCMS analysis of valproic acid metabolites and the effects of salicylate on valproic acid metabolism
by: Kassam, Jeanine Posset
Published: (2010) -
Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in breast cancer cell line
by: Ahmad Yarmohamadi, et al.
Published: (2018-01-01)